Rapt Therapeutics Inc (NASDAQ:RAPT)

19.39
Delayed Data
As of Mar 20
 +0.48 / +2.53%
Today’s Change
9.86
Today|||52-Week Range
32.45
-2.07%
Year-to-Date

Today’s Trading

Previous close18.94
Today’s open19.14
Day’s range18.68 - 19.49
Volume304,213
Average volume (3 months)469,134
Market cap$649.1M
Data as of 4:00pm ET, 03/20/2023

Growth & Valuation

Earnings growth (last year)-15.29%
Earnings growth (this year)-1.17%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.38%
P/E ratioNM
Price/Sales263.85
Price/Book3.06

Competitors

 Today’s
change
Today’s
% change
BCYCBicycle Therapeutics...-0.42-1.93%
ADMAADMA Biologics Inc-0.02-0.65%
IBRXImmunitybio Inc-0.06-4.26%
----
Data as of 3:59pm ET, 03/20/2023

Financials

Next reporting dateMay 10, 2023
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$3.8M
Annual profit (last year)-$69.2M
Net profit margin-1,814.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts